经皮冠状动脉腔内成形术后再狭窄分子生物学机制及基因治疗研究进展被引量：1

下载PDF

导出

摘要经皮冠状动脉腔内成形术后再狭窄分子生物学机制及基因治疗研究进展湖北省人民医院心内科胡成林综述许家，李庚山审校１９７７年瑞士科学家Ｇｒｔｉｎｔｚｉｇ［１］率先采用了经皮腔内冠状动脉成形术（ＰＴＣＡ）治疗冠状动脉狭窄获得成功并迅速推广。但术后再狭窄发生率...

作者胡成林

机构地区湖北省人民医院心内科

出处《心血管病学进展》 CAS 1995年第4期224-226,共3页 Advances in Cardiovascular Diseases

关键词冠状动脉成形术狭窄生物学机制基因疗法

同被引文献15

1郗永安.冠状动脉成形术后再狭窄的防治进展[J].心血管病学进展,1996,17(4):200-203. 被引量：2
2Bailey SR,Intravscular stent:Current applications.Curr.Proble.Cardiol.1995:9:618-617.
3Bonin PD,Singh JP,GammillRB,et al.Dipyridarrole directly in vitro and vivoimplicatins in the treament of restenosis after angioplaty,J Am Coll Cardiol.1994:23:665-673.
4Buchwald AB.Hammerschmidt S.Steveus J.et al.Inhibition of neointimal proliferation after coronary angioplasty by lowmolecular weight heperin(Clivarine) and polyethg leneylycolhirodin.J Cardio Vasc Phannscol 1996:28:481-187.
5Ali N,Mazur W,Kleiman NS,et al.Inhibition of coronary restenosis by antithrombin Ⅲ in atherosclerotic swine .Coron Artery Dis .1996;7:851-61.
6Strauss BH,Serruys PW,Bertrand ME et al.Quantitative angiographic follow-up of coronary wallstent in native veasel and bypass grafts(Earopean experience March 1986 to March 1990) Am J Cardiol 1992;69:475-81.
7Newby Ac,Gergoe SJ.Propsed roles for grosth factors in mediating smooth muscles proliferation in vasculatpathologic ,Cardiovascular Rescerch.1993;27:1173-1180.
8Wilcox JN,Molecular biology:insight into the cause and prevention.Am J Cardiol.1993;72:88E.
9Muller DNM. Ellia SG. Topol. Experimental models of corunary artery restenosis.J Am Coll Cardiol 1992;19:418-25.
10Emsherger P.Zhou J.Damon TH et al.Angiotensin Ⅱ recepter subtypes in cultured rat renal mesangial cells.Am J Physiol 1992;263:F441.

心血管病学进展

1995年第4期

内容加载中请稍等...